These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17671187)

  • 1. Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase.
    Satpathy M; Cao L; Pincheira R; Emerson R; Bigsby R; Nakshatri H; Matei D
    Cancer Res; 2007 Aug; 67(15):7194-202. PubMed ID: 17671187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase.
    Shao M; Cao L; Shen C; Satpathy M; Chelladurai B; Bigsby RM; Nakshatri H; Matei D
    Cancer Res; 2009 Dec; 69(24):9192-201. PubMed ID: 19951993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3.
    Gourley C; Paige AJ; Taylor KJ; Ward C; Kuske B; Zhang J; Sun M; Janczar S; Harrison DJ; Muir M; Smyth JF; Gabra H
    Cancer Res; 2009 Jun; 69(11):4835-42. PubMed ID: 19458077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: morphologic alteration and reduced expression of beta1 integrin subsets.
    Furuya M; Kato H; Nishimura N; Ishiwata I; Ikeda H; Ito R; Yoshiki T; Ishikura H
    Cancer Res; 2005 Apr; 65(7):2617-25. PubMed ID: 15805258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer.
    Yakubov B; Chelladurai B; Schmitt J; Emerson R; Turchi JJ; Matei D
    Neoplasia; 2013 Jun; 15(6):609-19. PubMed ID: 23730209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells.
    Herman JF; Mangala LS; Mehta K
    Oncogene; 2006 May; 25(21):3049-58. PubMed ID: 16449978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity.
    Satpathy M; Shao M; Emerson R; Donner DB; Matei D
    J Biol Chem; 2009 Jun; 284(23):15390-9. PubMed ID: 19324884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC-MS/MS analysis of ovarian cancer metastasis-related proteins using a nude mouse model: 14-3-3 zeta as a candidate biomarker.
    He Y; Wu X; Liu X; Yan G; Xu C
    J Proteome Res; 2010 Dec; 9(12):6180-90. PubMed ID: 21028892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
    Kotsakis P; Wang Z; Collighan RJ; Griffin M
    Amino Acids; 2011 Oct; 41(4):909-21. PubMed ID: 21046178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of fibronectin and tissue transglutaminase promotes cell invasion involving increased association with integrin and MMP expression in A431 cells.
    Chen SH; Lin CY; Lee LT; Chang GD; Lee PP; Hung CC; Kao WT; Tsai PH; Schally AV; Hwang JJ; Lee MT
    Anticancer Res; 2010 Oct; 30(10):4177-86. PubMed ID: 21036738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion.
    Sawada K; Radjabi AR; Shinomiya N; Kistner E; Kenny H; Becker AR; Turkyilmaz MA; Salgia R; Yamada SD; Vande Woude GF; Tretiakova MS; Lengyel E
    Cancer Res; 2007 Feb; 67(4):1670-9. PubMed ID: 17308108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression.
    Ohyagi-Hara C; Sawada K; Kamiura S; Tomita Y; Isobe A; Hashimoto K; Kinose Y; Mabuchi S; Hisamatsu T; Takahashi T; Kumasawa K; Nagata S; Morishige K; Lengyel E; Kurachi H; Kimura T
    Am J Pathol; 2013 May; 182(5):1876-89. PubMed ID: 23499550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin.
    Sima LE; Yakubov B; Zhang S; Condello S; Grigorescu AA; Nwani NG; Chen L; Schiltz GE; Arvanitis C; Zhang ZY; Matei D
    Mol Cancer Ther; 2019 Jun; 18(6):1057-1068. PubMed ID: 31015308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.
    Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A
    Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocyte-derived tissue transglutaminase interacts with fibronectin: a role in astrocyte adhesion and migration?
    van Strien ME; Brevé JJ; Fratantoni S; Schreurs MW; Bol JG; Jongenelen CA; Drukarch B; van Dam AM
    PLoS One; 2011; 6(9):e25037. PubMed ID: 21949843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting ovarian tumor cell adhesion mediated by tissue transglutaminase.
    Khanna M; Chelladurai B; Gavini A; Li L; Shao M; Courtney D; Turchi JJ; Matei D; Meroueh S
    Mol Cancer Ther; 2011 Apr; 10(4):626-36. PubMed ID: 21330459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α2,3-sialyltransferase type I regulates migration and peritoneal dissemination of ovarian cancer cells.
    Wen KC; Sung PL; Hsieh SL; Chou YT; Lee OK; Wu CW; Wang PH
    Oncotarget; 2017 Apr; 8(17):29013-29027. PubMed ID: 28423672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
    Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
    Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer.
    Miyake S; Kitajima Y; Nakamura J; Kai K; Yanagihara K; Tanaka T; Hiraki M; Miyazaki K; Noshiro H
    Int J Oncol; 2013 Nov; 43(5):1431-40. PubMed ID: 23970191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling.
    Cao L; Petrusca DN; Satpathy M; Nakshatri H; Petrache I; Matei D
    Carcinogenesis; 2008 Oct; 29(10):1893-900. PubMed ID: 18667446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.